Virpax Pharmaceuticals

+$0.10 (+2.44%) Today
-$0.02 (-0.48%) As of 12:11 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRPX and other ETFs, options, and stocks.

About VRPX

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray.

CEO
Anthony P. Mack
Employees
4
Headquarters
Berwyn, Pennsylvania
Founded
2016

VRPX Key Statistics

Market Cap
49.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
340.77K
High Today
$4.23
Low Today
$4.05
Open Price
$4.09
Volume
294.81K
52 Week High
$36.00
52 Week Low
$3.70

VRPX Earnings

-$0.60
-$0.40
-$0.20
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure